Kezar Life Sciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KZR and other ETFs, options, and stocks.About KZR
Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer. Its product pipeline includes KZR-616, KZR-261, and KZR-TBD.
CEOChristopher J. Kirk
CEOChristopher J. Kirk
Employees55
Employees55
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2015
Founded2015
Employees55
Employees55
KZR Key Statistics
Market cap46.50M
Market cap46.50M
Price-Earnings ratio-0.75
Price-Earnings ratio-0.75
Dividend yield—
Dividend yield—
Average volume37.01K
Average volume37.01K
High today$6.35
High today$6.35
Low today$6.24
Low today$6.24
Open price$6.24
Open price$6.24
Volume4.15K
Volume4.15K
52 Week high$6.95
52 Week high$6.95
52 Week low$3.53
52 Week low$3.53
Stock Snapshot
Kezar Life Sciences(KZR) stock is priced at $6.35, giving the company a market capitalization of 46.5M. It carries a P/E multiple of -0.75.
As of 2025-12-24, Kezar Life Sciences(KZR) stock has fluctuated between $6.24 and $6.35. The current price stands at $6.35, placing the stock +1.8% above today's low and 0.0% off the high.
Kezar Life Sciences(KZR) shares are trading with a volume of 4.15K, against a daily average of 37.01K.
In the last year, Kezar Life Sciences(KZR) shares hit a 52-week high of $6.95 and a 52-week low of $3.53.
In the last year, Kezar Life Sciences(KZR) shares hit a 52-week high of $6.95 and a 52-week low of $3.53.
People also own
Based on the portfolios of people who own KZR. This list is generated using Robinhood data, and it’s not a recommendation.